Table 1.
General characteristics of individuals screened for strongyloidiasis.
| Variable | Frequency |
|---|---|
| Age (n = 1943) | |
| Median (IQR) | 38 (31–48) |
| Group | |
| <25 | 201 (10.34%) |
| 26–39 | 846 (43.54%) |
| 40–54 | 652 (33.56%) |
| >54 | 244 (12.56%) |
| Male sex (n = 1634) | 947 (57.96%) |
| Hospitals | |
| Clinic | 902 |
| Vall d’Hebron | 411 |
| Hospital Poniente | 303 |
| Hospital Mar | 198 |
| Hospital Sant Pau | 70 |
| Hospital Bellvitge | 64 |
| Departments or units | |
| General services | 77 |
| Autoimmune/Rheumatology | 86 |
| Transplant units | 150 |
| Hemato-Oncology | 101 |
| International Health | 804 |
| HIV units | 709 |
| Other | 21 |
| Continents (n = 1876) | |
| Africa | 600 |
| North Africa | 141 |
| SSA | 459 |
| America | 1106 |
| South America | 934 |
| Central America &Caribe | 172 |
| Asia | 103 |
| South-Central Asia | 61 |
| South-East Asia Middle East | 273 |
| East Asia | 12 |
| Europe | 67 |
| West Europe | 53 |
| East Europe | 14 |